- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Aster DM Healthcare net profit leaps over six fold to Rs 42 crore in Q2
![Aster DM Healthcare net profit leaps over six fold to Rs 42 crore in Q2 Aster DM Healthcare net profit leaps over six fold to Rs 42 crore in Q2](https://medicaldialogues.in/h-upload/2020/04/27/750x450_127859-126233-funding.webp)
New Delhi: Healthcare provider Aster DM Healthcare on Tuesday posted over six-fold increase in its consolidated net profit at Rs 42.25 crore for the second quarter ended September 30.
The company had reported a net profit of Rs 6.87 crore in the July-September period of previous fiscal.
Total income during the period rose to Rs 2,275.65 crore as against Rs 2,091.01 crore in the year-ago period, Aster DM Healthcare said in a regulatory filing.
"Our businesses have come back to normal in the GCC, however, India operations are still lagging behind even though the new cases in India have dropped significantly in the last month," Aster DM Healthcare Founder Chairman and Managing Director Azad Moopen said.
The company believes that the innate strength in its diversified business model has helped it maintain the business amid the pandemic situation, he added.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751